ACUREX BIOSCIENCES Trademark

Trademark Overview

On Monday, December 21, 2020, a trademark application was filed for ACUREX BIOSCIENCES with the United States Patent and Trademark Office. The USPTO has given the ACUREX BIOSCIENCES trademark a serial number of 90981351. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Saturday, February 1, 2025. This trademark is owned by AcureX Therapeutics Corporation. The ACUREX BIOSCIENCES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development services in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; providing medical and scientific research and information in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; medical diagnostic research and pharmaceutical development services for drug discovery in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's, Alzheimer's, ALS, Huntington's, and diseases of aging
acurex biosciences

General Information

Serial Number90981351
Word MarkACUREX BIOSCIENCES
Filing DateMonday, December 21, 2020
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateSaturday, February 1, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

NOT AVAILABLEBIOSCIENCES
Goods and ServicesPharmaceutical research and development services in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; providing medical and scientific research and information in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; medical diagnostic research and pharmaceutical development services for drug discovery in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's, Alzheimer's, ALS, Huntington's, and diseases of aging

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 4, 2021
Primary Code042
First Use Anywhere DateFriday, March 31, 2023
First Use In Commerce DateFriday, March 31, 2023

Trademark Owner History

Party NameACUREX BIOSCIENCES CORPORATION
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressSAN CARLOS, CA 94070
Party NameAcureX Therapeutics Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Carolos, CA 94070
Party NameAcureX Therapeutics Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Carolos, CA 94070

Trademark Events

Event DateEvent Description
Saturday, June 19, 2021PRIORITY ACTION E-MAILED
Thursday, December 24, 2020NEW APPLICATION ENTERED
Thursday, March 4, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 16, 2021ASSIGNED TO EXAMINER
Thursday, September 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 23, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Saturday, June 19, 2021NOTIFICATION OF PRIORITY ACTION E-MAILED
Saturday, June 19, 2021PRIORITY ACTION WRITTEN
Thursday, September 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 21, 2022OPPOSITION INSTITUTED NO. 999999
Monday, February 13, 2023OPPOSITION TERMINATED NO. 999999
Monday, February 13, 2023TTAB RELEASE CASE TO TRADEMARKS
Wednesday, February 15, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, March 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 17, 2023SOU TEAS EXTENSION RECEIVED
Monday, July 17, 2023SOU EXTENSION 1 GRANTED
Monday, July 17, 2023SOU EXTENSION 1 FILED
Wednesday, July 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 13, 2024SOU EXTENSION 2 FILED
Thursday, March 14, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, September 29, 2024SOU TEAS EXTENSION RECEIVED
Sunday, September 29, 2024TEAS REQUEST TO DIVIDE RECEIVED
Monday, September 30, 2024USE AMENDMENT FILED
Monday, February 13, 2023OPPOSITION DISMISSED NO. 999999
Wednesday, March 13, 2024SOU EXTENSION 2 GRANTED
Sunday, September 29, 2024SOU EXTENSION 3 FILED
Sunday, September 29, 2024DIVISIONAL REQUEST RECEIVED
Sunday, September 29, 2024TEAS STATEMENT OF USE RECEIVED
Monday, September 30, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, December 10, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 17, 2025REVIEW OF CORRESPONDENCE COMPLETE
Friday, January 17, 2025DIVISIONAL PROCESSING COMPLETE
Friday, January 17, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, January 17, 2025SOU EXTENSION 3 GRANTED
Saturday, February 1, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, February 1, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, January 18, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

biosciences acurex diseases metabolic mitochondrial parkinson alzheimer aging huntington system disorders research